Interleukin-10 modulation of alloreactivity and graft-versus-host reactions

Transplantation

Volumn 74, Issue 6, 2002, Pages 772-778

  Wang, Xiao nong ^a   Lange, Claudia ^a   Schulz, Ute ^a   Sviland, Lisbet ^a   Eissner, Günther ^a   Oliver, Kristyna M ^a   Jackson, Graham H ^a   Holler, Ernst ^a   Dickinson, Anne M ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CYTOKINE; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ALLOIMMUNITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOLYSIS; EXPLANT; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0037183925     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200209270-00007     Document Type: Article

References (33)

1. de Vries JE. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med 1995; 27: 537.
2. Bejarano MT, de Waal Malefyt R, Abrams JS, et al. Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int Immunol 1992; 4: 1389.
3. Gorczynski RM, Wojcik D. A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion. J Immunol 1994; 152: 2011.
4. Hancock W, Mottram PL, Purcell LJ, et al. Prolonged survival of mouse cardiac allografts after CD4 or CD8 monoclonal antibody therapy is associated with selective intragraft cytokine protein expression: interleukin (IL)-4 and IL-10 but not IL-2 or interferon-gamma. Transplant Proc 1993; 25: 2937.
5. Bacchetta R, Bigler M, Touraine J-L, et al. High levels of IL-10 production in vivo are associated with tolerance in a SCID patient transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 1994; 179: 493.
6. Holler E, Roncarolo M-G, Hintermeier-Knabe R, et al. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 2000; 25: 237.
7. Baker KS, Roncarolo M-G, Peters C, et al. High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths. Bone Marrow Transplant 1999; 23: 1123.
8. Hempel L, Korholz D, Nussbaum P, et al. High interleukin 10 serum levels are associated with fatal outcome in patients after bone marrow transplantation. Bone Marrow Transplant 1997; 20: 365.
9. Roncarolo M-G. The role of interleukin-10 in transplantation and GVHD. In: Ferrara JLM, Deeg HJ, BurakoffSJ, eds. Graft-vs-host disease. New York: M Dekker; 1997, p 693.
10. Vogelsang GB, Hess AD, Berkman AW, et al. An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants. N Engl J Med 1985; 313: 645.
11. Dickinson AM, Sviland L, Wang XN, et al. Predicting graft-versus-host disease in HLA-identical bone marrow transplants: a comparison of T cell frequency analysis and a human skin explant model. Transplantation 1998; 66: 857.
12. Dickinson AM, Sviland L, Jackson G, et al. Cytokine involvement in predicting clinical graft versus host disease (GvHD) in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 65.
13. dim, CD86·) prolong cardiac allograft survival in nonimmunosupressed recipients. Transplantation 1996; 62: 659.
14. Steinbrink K, Wolfl M, Jonuleit H, et al. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997; 159: 4772.
15. Caux C, Massacrier C, Vanbervliet B, et al. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int Immunol 1994; 6: 1177.
16. Willems F, Marchant A, Delville JP, et al. Interleukin IL-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994; 24: 1007.
17. Lerner KG, Kao GF, Storb R, et al. Histopathology of graft-vs-host reaction (GvHR) in human recipients of marrow from HLA-matched sibling donors. Transplant Proc 1974; 6: 367.
18. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180: 83.
19. Hock D, Starling GC, Daniel PB, et al. Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells. J Immunol 1994; 83: 573-581.
20. Taga K, Mostowski H, Tosato G. Human interleukin-10 can directly inhibit T-cell growth. Blood 1993; 81: 2964.
21. Liu Y, Wei SH, Ho AS, et al. Expression cloning and characterization of a human IL-10 receptor. J Immunol 1994; 152: 1821.
22. Perrin GQ, Johnson HM. Mechanism of interleukin-10 inhibition of T-helper cell activation by superantigen at the level of the cell cycle. Blood 1999; 93: 208.
23. Groux H, Bigler M, de Vries JE, et al. Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol 1998; 160: 3188.
24. de Waal Malefyt R, Haanen J, Spits H, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915.
25. Enk AH, Angeloni VL, Udey MC, et al. Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J Immunol 1993; 151: 2390.
26. MacDonald HR. NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity and function. J Exp Med 1995; 182: 633.
27. Groux H, Powrie F. Regulatory T cells and inflammatory bowel disease. Immunol Today 1999; 20: 441.
28. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, et al. Interleukin-10 dose-dependent regulation of CD4+ and CD8+ T cell-mediated graft-versus-host disease. Transplantation 1998; 66: 1220.
29. Blazar BR, Taylor PA, Smith S, et al. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts. Blood 1995; 85: 842.
30. Krenger W, Snyder K, Smith S, et al. Effects of exogenous interleukin-10 in a murine model of graft-versus-host disease to minor histocompatibility antigens. Transplantation 1994; 58: 1251.
31. Korngold R, Sprent J. T cell subsets and graft-versus-host disease. Transplantation 1987; 44: 335.
32. Gibson AW, Edberg JC, Wu J, et al. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001; 166: 3915.
33. Dickinson AM, Cavet J, Cullup H, et al. GVHD risk assessment in hematopoietic stem cell transplantation: role of cytokine gene polymorphisms and an in vitro skin explant model. Hum Immunol 2001; 62: 1266.